---
figid: PMC6090282__fphar-09-00873-g013
figlink: /pmc/articles/PMC6090282/figure/F13/
number: F13
caption: Cartoon illustrating signaling pathways activated by temozolomide (TMZ) in
  glioma cells. TMZ plays a dual role by both (1) inhibiting cell proliferation (pink
  solid line) and (2) inducing acquired TMZ resistance via the upregulation of MGMT.
  The latter effect requires [Ca2+]i-dependent glycogenolysis via the Na,K-ATPase/ERK1/2signaling
  pathway (green solid lines). Activation of the second pathway leads to an increase
  in [Ca2+]i by TRPC1 in the cell membrane and IP3R in the ER, which act upon the
  intracellular Ca2+-sensitive site of calmodulin (CaM) protein, possibly activating
  glycogen phosphorylase activation and the subsequent stimulation of glycogenolysis,
  necessary for pathway function. The ouabain signaling pathway is shown at the top
  of the figure. Na,K-ATPase was activated possibly by glycogenolysis and trans-activated
  by the MAPK pathway, which was confirmed by our own previous studies and our current
  inhibitor studies. Inhibitory effects on the upregulation of MGMT expression, after
  addition of TMZ, are shown in brown ovals. No effect of other inhibitors on [Ca2+]i
  release and upregulation of Na,K-ATPase, ERK1/2, and MGMT are shown in green ovals.
pmcid: PMC6090282
papertitle: 'Glycogenolysis in Acquired Glioma Resistance to Temozolomide: A Role
  for the [Ca2+]i-dependent Activation of Na,K-ATPase/ERK1/2 Signaling.'
reftext: Junnan Xu, et al. Front Pharmacol. 2018;9:873.
pmc_ranked_result_index: '51948'
pathway_score: 0.9302465
filename: fphar-09-00873-g013.jpg
figtitle: Signaling pathways activated by temozolomide in glioma cells
year: '2018'
organisms:
- Homo sapiens
ndex: fe526135-df0a-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6090282__fphar-09-00873-g013.html
  '@type': Dataset
  description: Cartoon illustrating signaling pathways activated by temozolomide (TMZ)
    in glioma cells. TMZ plays a dual role by both (1) inhibiting cell proliferation
    (pink solid line) and (2) inducing acquired TMZ resistance via the upregulation
    of MGMT. The latter effect requires [Ca2+]i-dependent glycogenolysis via the Na,K-ATPase/ERK1/2signaling
    pathway (green solid lines). Activation of the second pathway leads to an increase
    in [Ca2+]i by TRPC1 in the cell membrane and IP3R in the ER, which act upon the
    intracellular Ca2+-sensitive site of calmodulin (CaM) protein, possibly activating
    glycogen phosphorylase activation and the subsequent stimulation of glycogenolysis,
    necessary for pathway function. The ouabain signaling pathway is shown at the
    top of the figure. Na,K-ATPase was activated possibly by glycogenolysis and trans-activated
    by the MAPK pathway, which was confirmed by our own previous studies and our current
    inhibitor studies. Inhibitory effects on the upregulation of MGMT expression,
    after addition of TMZ, are shown in brown ovals. No effect of other inhibitors
    on [Ca2+]i release and upregulation of Na,K-ATPase, ERK1/2, and MGMT are shown
    in green ovals.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRIT1
  - PIK3R5
  - AKT3
  - RAF1
  - AKT2
  - ARAF
  - PIK3R6
  - KCNH3
  - AKT1
  - MTOR
  - MAPK3
  - HRAS
  - KRAS
  - PIK3R4
  - JUN
  - GUCY2D
  - MAP2K1
  - PIK3R3
  - MGMT
  - BRAF
  - MAPK1
  - MAP2K2
  - NRAS
  - PIK3CA
  - RYR1
  - PIK3CB
  - TRPC1
  - SRC
  - PIK3CG
  - UBXN11
  - PIK3CD
  - FOS
  - Na
  - TMZ
  - Ca
  - K
  - Nifedipine
  - Canrenone
  - Ca2
  - Ryanodine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: CaM
  symbol: CAM
  source: hgnc_alias_symbol
  hgnc_symbol: KRIT1
  entrez: '889'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Elk2
  symbol: elk2
  source: hgnc_alias_symbol
  hgnc_symbol: KCNH3
  entrez: '23416'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Jun
  symbol: JUN
  source: hgnc_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: L-Ca
  symbol: LCA
  source: hgnc_prev_symbol
  hgnc_symbol: GUCY2D
  entrez: '3000'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MGMT
  symbol: MGMT
  source: hgnc_symbol
  hgnc_symbol: MGMT
  entrez: '4255'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RyR
  symbol: RYR
  source: hgnc_alias_symbol
  hgnc_symbol: RYR1
  entrez: '6261'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: TRPC1
  symbol: TRPC1
  source: hgnc_symbol
  hgnc_symbol: TRPC1
  entrez: '7220'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Soc
  symbol: SOC
  source: hgnc_alias_symbol
  hgnc_symbol: UBXN11
  entrez: '91544'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Fos
  symbol: FOS
  source: hgnc_symbol
  hgnc_symbol: FOS
  entrez: '2353'
chemicals:
- word: Na
  source: MESH
  identifier: D012964
- word: TMZ
  source: MESH
  identifier: C047246
- word: Ca
  source: MESH
  identifier: D002118
- word: K
  source: MESH
  identifier: D011188
- word: Nifedipine
  source: MESH
  identifier: D009543
- word: Canrenone
  source: MESH
  identifier: D002192
- word: Ca2
  source: MESH
  identifier: D002118
- word: Ryanodine
  source: MESH
  identifier: D012433
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC6090282__F13
redirect_from: /figures/PMC6090282__F13
figtype: Figure
---
